The effect of inhaled nitric oxide on 6-minute walk distance in patients with pulmonary hypertension

Chest

Volumn 114, Issue 1 SUPPL., 1998, Pages 70S-72S

  Parsons, S ^a   Celermajer, D ^a   Savidis, E ^a   Miller, O ^a   Young, I ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PLACEBO;

ADULT; AGED; ARTERIAL OXYGEN SATURATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPNEA; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; LUNG VENTILATION; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; TREADMILL EXERCISE; WALKING;

EID: 0031853360     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.1_Supplement.70S     Document Type: Conference Paper

References (8)

1. Weir EK, Rubin LJ, Ayres SM, et al. The acute administration of vasodilators in primary pulmonary hypertension. Am Rev Respir Dis 1989; 140:1623-30
2. Moinard J, Manier G, Pillet O, et al. Effect of inhaled nitric oxide on hemodynamics and VA/Q inequalities in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 149:1482-87
3. Channick RN, Hoch RC, Newhart JW, et al. Improvement in pulmonary hypertension and hypoxemia during nitric oxide inhalation in a patient with end-stage pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149:811-14
4. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327:76-81
5. Pepke-Zaba J, Higenbottam T, Dinh-Xuan AT, et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338:1173-74
6. Nootens M, Schrader B, Kaufmann E, et al. Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension. Chest 1995; 107:54-57
7. Raffy O, Azarian R, Brenot F, et al. Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension. Circulation 1996; 93:484-88
8. Barst RJ, Rubin LJ, McGoon MD, et al. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med 1994; 121:409-15